Showing results (91-100 of 139) with videos related to

Sort By:
Pageof 14
Cancer Chemotherapy and Pharmacology|July 16, 2025
DNA-incorporated thioguanine to detect potential non-adherence to maintenance therapy in acute lymphoblastic leukemiaMathilde Rønne Koch, Anna Sofie Buhl Rasmussen, Bodil Als-Nielsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2026
Sustained Benefit of Blinatumomab in Infants With <i>KMT2A</i>-Rearranged ALL: Long-Term Outcomes, Toxicity, and PharmacokineticsMiguel Vieira Martins, Paola de Lorenzo, Rishi S Kotecha, et al.
Oncotarget|November 29, 2016
Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemiaJudith M Boer, Elisabeth M P Steeghs, João R M Marchante, et al.
British Journal of Haematology|August 4, 2017
Neurotoxic side effects in children with refractory or relapsed T-cell malignancies treated with nelarabine based therapyMichaela Kuhlen, Kirsten Bleckmann, Anja Möricke, et al.
The Lancet. Oncology|June 15, 2016
Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensusKjeld Schmiegelow, Andishe Attarbaschi, Shlomit Barzilai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemiaKjeld Schmiegelow, Mette Frandsen Levinsen, Andishe Attarbaschi, et al.
The New England Journal of Medicine|April 13, 2012
Outcomes after induction failure in childhood acute lymphoblastic leukemiaMartin Schrappe, Stephen P Hunger, Ching-Hon Pui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2023
Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary TrialsElizabeth A Raetz, Paola Rebora, Valentino Conter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2022
Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/<i>KMT2A</i> Rearrangements in a Modern Therapy Era: A Retrospective International StudyAndishe Attarbaschi, Anja Möricke, Christine J Harrison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Childhood Acute Lymphoblastic Leukemia: Progress Through CollaborationChing-Hon Pui, Jun J Yang, Stephen P Hunger, et al.
Pageof 14